Content area

|
|

Reduceret risiko for diabetes og kardiovaskulær sygdom efter fedmekirurgi

Forfatter(e)

Ida Kirstine Bull Rasmussen1, Søren Sandager Petersen2, Jacob Juel3, Morten Rix Hansen4, 5, Niels Holmark Andersen6 & Manan Pareek2, 7, 8

1) Medicinsk Afdeling, Sjællands Universitetshospital, Roskilde 2) Endokrinologisk Afdeling, Odense Universitetshospital 3) Plastikkirurgisk Afdeling, Aalborg Universitetshospital 4) Klinisk Farmakologi og Farmaci, Det Sundhedsviden-skabelige Fakultet, Syddansk Universitet 5) Afdeling for Klinisk Biokemi og Farmakologi, Odense Universitetshospital 6) Kardiologisk Afdeling, Aalborg Universitetshospital 7) Brigham and Women’s Hospital Heart & Vascular Center, Harvard Medical School 8) Medicinsk Afdeling, Holbæk Sygehus Ugeskr Læger 2018;180:V10170782

Reference: 
Ugeskr Læger 2018;180:V10170782
Blad nummer: 
Sidetal: 
2-7
Reduced risk of diabetes and cardiovascular disease after bariatric surgery

The worldwide incidence of obesity, defined as a BMI ≥ 30 kg/m2, has more than doubled during the past four decades. Bariatric/metabolic surgery provides the largest and most sustainable degree of weight loss. This review briefly summarises the emerging randomised evidence of the superiority of these procedures over conventional treatment, in achieving glycaemic control and inducing remission in patients with type 2 diabetes as well as the observational evidence suggesting improvements in the long-term risks of cardiovascular outcomes and mortality.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Finn Redke | 24/04
2 kommentarer
af Christian Schlütter | 23/04
1 Kommentar
af Frede Simonsen | 20/04
2 kommentarer
af Hans Storm Erichsen | 19/04
1 Kommentar
af Debatred. | 15/04
1 Kommentar
af Martin Bonde Petersen | 15/04
1 Kommentar
af Anne Lisbeth Hoffmann | 15/04
4 kommentarer
af Jørgen Lous | 13/04
9 kommentarer